[Skip to Content]
[Skip to Content Landing]
Views 1,004
Citations 0
Comment & Response
July 16, 2019

Cannabis as a Substitute for Opioids—Reply

Author Affiliations
  • 1Stanford University School of Medicine, Palo Alto, California
  • 2Boston University School of Public Health, Boston, Massachusetts
  • 3JAMA, Chicago, Illinois
JAMA. 2019;322(3):273-274. doi:10.1001/jama.2019.6471

In Reply Dr Gonzalez and colleagues provide detail regarding the New York State Medical Marijuana Program, noting that dispensaries overseen by pharmacists sell regulated products and that certifying practitioners must consult a prescription monitoring program. Some regulation of putatively medical cannabis is clearly better than none, but the New York standards are well below those set for the practice of medicine generally, in which preferred prescribed medications have clinical trial–derived evidence of efficacy and safety in specific doses for specific conditions.